This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

WellPoint Selects Cerner To Launch ICD-10 Business Continuity Test Program

KANSAS CITY, Mo., March 1, 2013 (GLOBE NEWSWIRE) -- Cerner (Nasdaq:CERN) announces it has been selected by WellPoint, Inc., the second largest health benefits company in the United States, to join forces on a project to test ICD-10 business continuity. As a selected electronic medical records (EMR) and Revenue Management supplier, Cerner will conduct thorough ICD-9 to ICD-10 end to end testing with WellPoint for a select set of clients.

The ICD-10 transition can significantly impact the overall revenue of health care organizations. The goal of the project is to prove that the end to end process will work within all the systems.

"Early testing with natively coded ICD-10 claims provided insights into legitimate shifts in reimbursement with certain methodologies, changes in behavior of system / business rules, and changes to analytics," said Ian Bonnet, Vice President with WellPoint, which serves approximately 36 million people through their affiliated health plans and approximately 67 million people through subsidiaries.

"Cerner's footprint in clinical systems and revenue cycle support made them a natural choice for collaborating on ICD-10 testing and we're excited about the insights both organizations and our shared stakeholders will receive," said Ian Bonnet.

"Participating in this project will allow us to test our integrated clinical and financial systems prior to the ICD-10 transition to ensure we're ready to support our clients through the event," said Rick Heise, Cerner vice president and executive sponsor of the project. "With an estimated 40-50% reduction in coding productivity being predicted, our clients need to know they can count on the workflow of Cerner systems involved in physician documentation, medical coding, billing and interface to communicate with, their clearinghouses and payers."

In order to test for business continuity, the project will run through the following steps to assure that end to end processes work within the systems of all stakeholders:
  • Health care providers chosen to be part of the pilot will select cases that have been submitted and paid coded in ICD-9.
  • The providers will then re-code the cases in ICD-10.
  • Cerner will be able to take that information through its systems, out through a clearinghouse and to WellPoint the payer and back to Cerner through a report containing 835 data.
  • Cerner ® solutions involved in testing will include Financial Hub, Patient Accounting and all systems involved in medical coding, billing and interface to clearinghouses.

Providers are currently being selected and the testing process should begin towards the end of 2013.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 -1.15%
FB $117.58 0.73%
GOOG $693.01 0.29%
TSLA $240.76 -2.81%
YHOO $36.60 0.03%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs